Harmful opioid use, including heroin, oxycodone and hydrocodone, and opioid use disorders remain a critical national public health concern. There are several FDA-approved medications to assist in the treatment of opioid use disorders and each of these medications offers individuals a somewhat different approach. This training will focus on enhancing understanding of the role of methadone, buprenorphine, and oral and extended-release naltrexone in treating opioid use disorders. The training will provide an overview of the research related to the use of these medications for both adults and young adults, as well as the practical issues related to providing coordinated care for individuals utilizing these medications as a treatment intervention. This training will also provide information about the use of the naloxone (Narcan) in the treatment of opioid overdose and as an overdose prevention tool.
This is a Private Event: Registration only open to the King County workforce.
Drawing from SAMHSAâ€™s TIP 52, this course is designed to increase understanding and skill in assessing counselors in substance use treatment settings and building learning plans to guide their continued professional growth and development. It emphasizes the importance of structure and the collaborative teaching and mentoring aspects of clinical supervision. The basis for evaluation are: SAMHSAâ€™s TAP 21 Addiction Counseling Competencies and Performance Assessment Rubrics for the Addiction Counseling Competencies. The content is generalizable to mental health and other settings. Experiential activities will enhance understanding of (a) culture in supervision, (b) methods of observation, (c) performance evaluation, (d) negotiation of learning plans, and (e) structuring of supervisory interviews.